Are you Matthew K. Flynn, M.D.? This profile is yours to edit: update your address, phone, photo and services.
Edit this profileListed in the NPI registry as a specialist, Matthew K. Flynn, M.D. practices in Raleigh, NC. Matthew graduated from Duke University School of Medicine in 1996. Matthew is also listed as specializing in dermatology. According to Medicare claims data, Matthew cared for 1,978 Medicare patients across 4,102 services. The services billed most often include destruction of precancer skin growth, 2-14 growths, established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more, and destruction of precancer skin growth, 1 growth. NPI 1689678336 identifies this record in the national registry.
Factual summary compiled by Guide.md from public records; not written by this provider.
Exactly as CMS reports it (National Downloadable File, Opt-Out Affidavits, Order & Referring). Not an insurance directory; confirm coverage with the office.
5603 DURALEIGH RD STE 111
Raleigh, NC 27612
4,102 services · 1,978 patients · 20 distinct codes
| Procedure | Type | Code | Services | Compared with peers |
|---|---|---|---|---|
| Destruction of precancer skin growth, 2-14 growths | Procedure | 17003 |
1,912 | More often than most peers in Specialist |
| Destruction of precancer skin growth, 1 growth | Procedure | 17000 |
566 | More often than most peers in Specialist |
| Biopsy of related skin growth, first growth | Procedure | 11102 |
233 | More often than most peers in Specialist |
| Biopsy of related skin growth, each additional growth | Procedure | 11103 |
95 | More often than most peers in Specialist |
| Destruction of skin growth, 1-14 growths | Procedure | 17110 |
77 | As often as other peers in Specialist |
| Destruction of precancer skin growth, 15 or more growths | Procedure | 17004 |
32 | Less often than most peers in Specialist |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Procedure | 12032 |
31 | As often as other peers in Specialist |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Procedure | 11602 |
28 | As often as other peers in Specialist |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Procedure | 17262 |
27 | As often as other peers in Specialist |
| Biopsy of ear | Procedure | 69100 |
24 | As often as other peers in Specialist |
Source: CMS Medicare public data. Shows how often procedures were billed — not quality of care or patient satisfaction.
Matthew K. Flynn is a specialist in Raleigh, NC. That is the designation recorded for this NPI in the federal registry.
NPI registry
Matthew K. Flynn is listed at 5603 Duraleigh Rd Ste 111, Raleigh, NC 27612. Addresses come from the NPI registry and can lag a move, so confirm before travelling.
NPI registry
The number on file is (919) 791-0840. Contact the office directly to confirm availability and scheduling.
NPI registry
Matthew K. Flynn's National Provider Identifier is 1689678336. It is issued by the Centers for Medicare & Medicaid Services and is unique and permanent — it does not change if they move practice.
NPI registry
Matthew K. Flynn attended Duke University School of Medicine, graduating in 1996. This comes from the CMS National Downloadable File.
CMS public data
Matthew K. Flynn has 30 years experience. Calculated from a graduation year of 1996, reported in the CMS National Downloadable File.
CMS public data
According to Medicare billing data, Matthew K. Flynn performs procedures including destruction of precancer skin growth, 2-14 growths, destruction of precancer skin growth, 1 growth and biopsy of related skin growth, first growth, alongside routine visits and testing. This reflects Medicare patients only and is billing volume, not a measure of quality.
Medicare claims
Not yet. This profile is built from public federal data and has not been confirmed by Matthew K. Flynn. If this is you, claiming it is free.
Guide.md
Guide.md listings do not constitute medical advice or an endorsement.
A GigHz company · Founder: Pouyan Golshani, MD